$145.10
-0.9549[-0.65%]
At close: Apr 26
AstraZeneca
(OTCPK:AZNCF)Latest News for AstraZeneca Stock (OTC:AZNCF)
AstraZeneca Stock (OTC: AZNCF)
Categories: All
Tuesday, November 14, 2023
Monday, September 11, 2023
- AztraZeneca's Tagrisso Plus Chemotherapy Extended Median Progression-free Survival By Nearly 9 Months In EGFR-Mutated Advanced Lung Cancer In FLAURA2 Phase 3 TrialBenzinga Newsdesk - Sep 11, 2023, 4:31AM
- AstraZeneca, Daiichi Sankyo's Datopotamab Deruxtecan Plus Imfinzi With Or Without Chemotherapy Demonstrated Objective Response Rates Of 77% And 50% And Disease Control Rates Of 92% And 93%, Respectively In Untreated Lung Cancer PatientsBenzinga Newsdesk - Sep 11, 2023, 4:29AM
Friday, July 28, 2023
- AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio PrioritizationVandana Singh - Jul 28, 2023, 1:51PM
- AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots UpVandana Singh - Jul 28, 2023, 8:46AM
- Ionis Has Expanded Its Existing Collaboration With AstraZeneca To Include Exclusive Rights For AstraZeneca To Commercialize Eplontersen In Latin America. Ionis Previously Granted Astrazeneca Exclusive Rights To Commercialize Eplontersen Outside USBenzinga Newsdesk - Jul 28, 2023, 7:08AM
- Alexion, AstraZeneca Rare Disease Agreed To Purchase And License An Agreement For A Portfolio Of Preclinical Gene Therapy Programs From Pfizer For A Total Consideration Of Up To $1B, Plus Tiered Royalties On SalesBenzinga Newsdesk - Jul 28, 2023, 3:35AM
Tuesday, July 18, 2023
Monday, July 03, 2023
Thursday, June 29, 2023
Monday, June 26, 2023
Wednesday, June 21, 2023
Tuesday, June 20, 2023
Friday, June 09, 2023
- AstraZeneca's Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood DisorderVandana Singh - Jun 9, 2023, 8:44AM
- AstraZeneca Inks Over $2B Agreement For Cell Therapies Targeting DiabetesVandana Singh - Jun 9, 2023, 8:14AM
- Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the HorizonVandana Singh - Jun 9, 2023, 8:07AM
Monday, June 05, 2023
Friday, May 26, 2023
Friday, May 19, 2023
Wednesday, May 17, 2023
- One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie FootstepsVandana Singh - May 17, 2023, 9:29AM
- AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung CancerVandana Singh - May 17, 2023, 8:15AM
- Astrazeneca's Tagrisso (Osimertinib) Combined With Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Improvement In Progression-free Survival Compared To Tagrisso Alone For A Certain Type Of Non-small Cell Lung CancerBenzinga Newsdesk - May 17, 2023, 3:59AM